| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/07/2006 | EP1414487B1 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers |
| 06/07/2006 | EP1409673B1 Human leucine-rich repeat containing protein, expressed predominantely in small intestine, hlrrsi1 |
| 06/07/2006 | EP1364023B1 Gene highly expressed in cartilage tissues |
| 06/07/2006 | EP1352091B1 Compositions and methods enabling a totally internally controlled amplification reaction |
| 06/07/2006 | EP1323732B1 Beta-catenin nuclear localizing protein |
| 06/07/2006 | EP1315738A4 Extended native chemical ligation |
| 06/07/2006 | EP1307210B1 Method and device for concentrating and stabilising conjugated oestrogens from the urine of mares |
| 06/07/2006 | EP1285654B1 Autonomic system controlling agents and health drinks and foods |
| 06/07/2006 | EP1265630B1 Use of insulin for the treatment of cartilagenous disorders |
| 06/07/2006 | EP1265629B1 Use of growth hormone in low dose |
| 06/07/2006 | EP1222931B1 Percutaneous absorption promoters for electroporation |
| 06/07/2006 | EP1171594B1 Vascular endothelial cell growth factor variants and uses thereof |
| 06/07/2006 | EP1165112B1 Modulators of polysaccharides and uses thereof |
| 06/07/2006 | EP1121941B1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 06/07/2006 | EP1107794B1 Therapeutic compositions for the treatment of mucus hypersecretion |
| 06/07/2006 | EP1105419B1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 06/07/2006 | EP1104307B1 Pharmaceutical composition having inhibitory effect on overproduction and accumulation of extracellular matrix |
| 06/07/2006 | EP1095059B1 Chemotaxis inhibiting protein of staphylococcus (chips) and its use |
| 06/07/2006 | EP1068233B1 Transcription factors and their use |
| 06/07/2006 | EP1051620B1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha |
| 06/07/2006 | EP1038015B1 Mood disorder gene |
| 06/07/2006 | EP1017789B1 Nucleic acid encoding a lectin-derived progenitor cell preservation factor |
| 06/07/2006 | EP1002081B1 Delayed progression to aids by a missense allele of the ccr2 gene |
| 06/07/2006 | EP0972015B1 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity |
| 06/07/2006 | EP0969873B1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
| 06/07/2006 | EP0939767B1 Porcine factor viii and hybrids thereof |
| 06/07/2006 | EP0885293B1 Human chemokine polypeptides |
| 06/07/2006 | EP0813538B1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 06/07/2006 | EP0772437B1 Compositions for delivery of genetic material |
| 06/07/2006 | CN1784423A Peptides for use in treating obesity |
| 06/07/2006 | CN1784422A Severe acute respiratory syndrome (SARS) causing coronavirus |
| 06/07/2006 | CN1784421A Immunogenic human TNF alpha analogues with reduced cytotoxicity and methods of their preparation |
| 06/07/2006 | CN1784420A Method for the production of an N-terminally modified chemotactic factor |
| 06/07/2006 | CN1784248A Needleless syringe having medical agent accommodated therein |
| 06/07/2006 | CN1784244A Prodrugs cleavable by CD26 |
| 06/07/2006 | CN1784241A Glutamate receptor antagonists as neuroprotectives |
| 06/07/2006 | CN1784240A Alzheimer's disease treatment method |
| 06/07/2006 | CN1784239A Protease inhibitors for coronaviruses and SARS-COV and the use thereof |
| 06/07/2006 | CN1784146A Peptides having an ace inhibiting effect |
| 06/07/2006 | CN1784145A Hydrolysed casein product comprising tripeptides ipp and/ or vpp |
| 06/07/2006 | CN1782083A Novel thrombase-like gene and its use |
| 06/07/2006 | CN1781947A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781946A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781945A Modified peptides as therapeutic agents |
| 06/07/2006 | CN1781943A South China sea conus littertus linnaeus nervotoxin and its coding sequence and use |
| 06/07/2006 | CN1781941A Protein Akaan 1 extracted from antrodia camphorata and its use in regulating immune function |
| 06/07/2006 | CN1781940A A group of long acting anti-retrovirus polypeptides and their preparing method and use |
| 06/07/2006 | CN1781939A Amidated horseshoe crab anti-endotoxin factor circular analogue peptide molecule, its synthetic method and use |
| 06/07/2006 | CN1781938A Method for preparing echinocandin derivatives |
| 06/07/2006 | CN1781937A Amidated horseshoe crab anti endotoxin factor linear analogue peptide molecule, its synthetic method and use |
| 06/07/2006 | CN1781935A Novel LHRH antagonist |
| 06/07/2006 | CN1781934A HER-2 analogue antigen epitope and peptide containing said epitope |
| 06/07/2006 | CN1781933A Thymosin alpha 1 active segment cyclicpeptide analogue and its poly glycol derivative |
| 06/07/2006 | CN1781932A Adriamycin derivative and its preparing method and use |
| 06/07/2006 | CN1781916A Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/07/2006 | CN1781555A High viscosity liquid controlled delivery system |
| 06/07/2006 | CN1781551A Fumor invasion and metastasis resisting function and use of venin cysteine proteinase inhibitor |
| 06/07/2006 | CN1781550A Injection for lactagogue |
| 06/07/2006 | CN1781549A Adeno-associated virus vector preparation and medicinal composition containing it and its use |
| 06/07/2006 | CN1781548A Medicinal preparation for treating stomach and intestine diseases and its preparing method |
| 06/07/2006 | CN1781511A Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof |
| 06/07/2006 | CN1258594C Long-noded pit viper poison dissolving fiber protein No.2 gene and use thereof |
| 06/07/2006 | CN1258589C Method of isolating bi-potent hepatic progenitor cells |
| 06/07/2006 | CN1258563C Highly-neutralized ethylene copolymers and their use in golf balls |
| 06/07/2006 | CN1258551C Preparing method of degradable polymer |
| 06/07/2006 | CN1258538C Recombinant protein |
| 06/07/2006 | CN1258537C Method for preparing polypeptide soluble in aqueous solvent in absence of detergent |
| 06/07/2006 | CN1258381C Botulinum toxin in the treatment or prevention of acne |
| 06/07/2006 | CN1258380C Utilization of ADAMTS-1 protein and method of screening aggrecanase activity regulator |
| 06/07/2006 | CN1258379C Botulinum toxin pharmaceutical composition |
| 06/07/2006 | CN1258353C Cosmetic and pharmaceutical composition and its use |
| 06/07/2006 | CN1258327C 液体抗微生物组合物 Liquid anti-microbial composition |
| 06/06/2006 | USRE39118 treating atopic dermatitis, psoriasis, ichthyosis, Fabry's disease, Gaucher's disease, Tay-Sachs disease or Sjogren-Larsson's syndrome btopically applying a composition containing a neutral sphingomyelinase obtained from lactic bacteria in the form of sonicated cells. |
| 06/06/2006 | US7057029 membrane/transport proteins; pharmacogenetics; drug screening |
| 06/06/2006 | US7057022 Antibodies which specifically bind to TNF-R |
| 06/06/2006 | US7057017 Human dickkopf-related protein and nucleic acid molecules and uses therefor |
| 06/06/2006 | US7057014 dissolving nonapeptides/decapeptides (luteinizing hormone-releasing hormone antagonists) in solvent mixture comprising water and alcohol (methanol), stirring with methyl acetate, preciptating, washing, then drying |
| 06/06/2006 | US7057013 TGFβ1 inhibitor peptides |
| 06/06/2006 | US7057012 PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules |
| 06/06/2006 | US7056950 Compositions of biochemical compounds involved in bioenergy metabolism of cells |
| 06/06/2006 | US7056947 For inhibiting (cysteine) proteases/caspases; for treatment of viral infections, stroke, neurodegenerative disease, and inflammatory diseases |
| 06/06/2006 | US7056935 Administering to the animal suffering from neurological disorders an amide compound having an affinity for FKBP-type immunophilins |
| 06/06/2006 | US7056909 5,5-Difluoro-3(S)-(pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro-(1, 8)-naphthyridin-2-yl)-nonanoic acid; inhibition of bone resorption, restenosis, angiogenesis, retinopathy, macular degeneration, arthritis, metastatic tumor growth, etc. |
| 06/06/2006 | US7056893 Topical treatment for prevention of ocular infections |
| 06/06/2006 | US7056889 For modulating mucus production at mucosal surfaces |
| 06/06/2006 | US7056887 Treatment of acute coronary syndrome with GLP-1 |
| 06/06/2006 | US7056886 GLP-2 formulations |
| 06/06/2006 | US7056885 Fibroblast growth factor and nucleic acids encoding same |
| 06/06/2006 | US7056884 Reduced FK228 and use thereof |
| 06/06/2006 | US7056883 Therapeutic agent for soft tissue sarcoma |
| 06/06/2006 | US7056882 Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| 06/06/2006 | US7056735 Mimetics and inhibitors of the interaction between Vpr (HIV viral protein of regulation) and ANT (Mitochondrial adenine nucleotide translocator) |
| 06/06/2006 | US7056734 Differentiation of non-insulin producing cells into insulin producing cells by GLP-1 or exendin-4 and uses thereof |
| 06/06/2006 | US7056729 Botulinum neurotoxin-substance P conjugate or fusion protein for treating pain |
| 06/06/2006 | US7056722 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 06/06/2006 | US7056720 LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapies |
| 06/06/2006 | US7056719 Polypeptide-phosphatidic acid phosphatase 29.81 and the polynucleotide encoding said polypeptide |
| 06/06/2006 | US7056712 Administering to the individual therapeutically effective amount of human acid alpha-glucosidase at regular interval for therapy of glycogen storage disease type II |
| 06/06/2006 | US7056711 Attenuation of fibroblast proliferation |
| 06/06/2006 | US7056704 RNA interference mediating small RNA molecules |